NCT06017739|UnknownDMC
Expiratory Flow Accelerator (Efa) vs Efa + High Flow in Chronic COPD and Bronchiectasis
Hypersecreting Patients (COPD And/or Bronchiectasic) Comparing 2 Technologies: Efa vs Efa + High Flow
Loading search results
Hypersecreting Patients (COPD And/or Bronchiectasic) Comparing 2 Technologies: Efa vs Efa + High Flow
Sponsor study identifier
interventional
20
1 country
1
Study Start
October 9, 2023
Actual (reported)Primary Completion
July 18, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
January 18, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The aim of the study is to compare the efficacy of using EFA technology versus the combination of EFA + high flow in hypersecretory patients COPD and bronchiectasis
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 18, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 18, 2023
Actual (reported)August 30, 2023
Actual (reported)October 9, 2023
Actual (reported)July 18, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
January 18, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Cough Severity
Visual Analogic Scale (0=not severe cough;10=very severe cough)
"Day0", "Week6", Week13"
Expectoration Difficulty
Visual Analogic Scale (0=not severe expectoration difficulty;10= very severe expectoration difficulty)
"Day0", "Week6", Week13"
FEV 1 (Forced Expiratory Volume)
"Day0", "Week6", Week13"
Exacerbations
"Day0", "Week6", Week13"
Inspiratory Capacity
"Day0", "Week6", Week13"
6 minutes walking test
"Day0", "Week6", Week13"
Saint George Respiratory Questionnaire
"Day0", "Week6", Week13"
Patients for 6 weeks use the Expiratory Flow Accelerator Technology
Patients for 6 weeks use the EFA technology and High Flow Technology
EFA technology: the patient has to breathe at tidal volume by a mouthpiece at level 5 for half an hour twice a day.
High Flow Technology: patient has to wear nasal cannula and breathe his nose for one hour twice a day. After he has to use EFA technology level 5 for half an hour twice a day.
Marianna Messina
Somma Lombardo, Varese, 21019, Italy
Marianna Messina
ASST Valle Olona
First Submitted
August 18, 2023
First Posted
August 30, 2023
Study Start
October 9, 2023
Actual (reported)Primary Completion
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
July 18, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
January 18, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
February 6, 2024
Record last verified: 2024-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: